ID MEDICAL GROUP LIMITED
Get an alert when ID MEDICAL GROUP LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-12-31 (in 7mo)
Last filed for 2025-03-31
Confirmation statement due
2026-08-20 (in 3mo)
Last made up 2025-08-06
Watchouts
None on the register
Cash
£613K
+35.6% vs 2024
Net assets
£6M
+10.2% vs 2024
Employees
227
-7.3% vs 2024
Profit before tax
£694K
-83.9% vs 2024
Name history
Renamed 5 times since incorporation
- ID MEDICAL GROUP LIMITED 2013-04-15 → present
- THE ID GROUP LIMITED 2003-10-28 → 2013-04-15
- ID GROUP LIMITED 2002-10-10 → 2003-10-28
- PHARMA-ID.COM LIMITED 2000-12-29 → 2002-10-10
- PHARMA-NET.COM LTD 2000-05-10 → 2000-12-29
- PHARMAPAGES LIMITED 1999-08-23 → 2000-05-10
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2025-03-31
| Metric | Trend | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Turnover | £227,422,268 | £167,307,995 | |
| Operating profit | £5,316,647 | £1,285,084 | |
| Profit before tax | £4,309,454 | £694,370 | |
| Net profit | £3,214,100 | £553,101 | |
| Cash | £451,802 | £612,842 | |
| Total assets less current liabilities | £5,432,897 | £5,990,090 | |
| Net assets | £5,432,897 | £5,985,998 | |
| Equity | £5,432,897 | £5,985,998 | |
| Average employees | 245 | 227 | |
| Wages | £13,600,875 | £11,769,021 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating margin | 2.3% | 0.8% | |
| Net margin | 1.4% | 0.3% | |
| Return on capital employed | 97.9% | 21.5% | |
| Current ratio | 1.19x | 1.25x | |
| Interest cover | 5.28x | 2.18x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Company continues to generate positive cashflows with sufficient liquidity and report positive net reserves which is expected to continue for the foreseeable future, and at least beyond the next 12 months. This view is based on a comprehensive going concern assessment of the Group as a whole, which includes an assessment for the Company.”
Group structure
- ID MEDICAL GROUP LIMITED · parent
- ID Medical Limited 100%
- ID Search & Selection Limited 100%
- ID Medical India LLP 99%
Significant events
- “During this financial year ending 31 March 2025, strikes continued to take place across the country by NHS front line staff and further industrial action by NHS employees is expected.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 14 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BRADBURY, Jonathan Paul | Director | 2019-06-03 | Jan 1976 | British |
| MACNEEL, Laura | Director | 2024-01-10 | Jul 1982 | American |
| PATEL, Deenu Rajeshbhai | Director | 2007-02-01 | Oct 1979 | British |
| ZEEB, Amber Lee | Director | 2024-01-10 | Sep 1979 | American |
Show 14 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ALDEN, Lynne | Secretary | 2018-04-12 | 2023-04-12 |
| BRADBURY, Jonathan Paul | Secretary | 2023-04-12 | 2024-01-10 |
| SACOOR, Michael | Secretary | 2000-10-27 | 2018-04-12 |
| FIRST SECRETARIES LIMITED | Corporate Nominee Secretary | 1999-08-23 | 2000-10-27 |
| BRAYNIN, Alan | Director | 2024-01-10 | 2025-05-04 |
| BRIMSON, Gus Haydn | Director | 2018-06-06 | 2024-01-10 |
| BRUCE, David Julian | Director | 2016-11-01 | 2018-06-06 |
| MOSS, Andrew John | Director | 2018-06-06 | 2018-10-09 |
| NANDHA, Ranjit Singh | Director | 2013-03-28 | 2023-08-05 |
| NEWTON, David Simbarashe | Director | 2009-01-01 | 2024-01-10 |
| SACOOR, Mahomed Hanif Allimahomed, Dr | Director | 1999-08-23 | 2024-01-10 |
| SACOOR, Michael | Director | 1999-08-23 | 2024-01-10 |
| THYGESEN, Stefan | Director | 2018-06-06 | 2024-01-10 |
| FIRST DIRECTORS LIMITED | Corporate Nominee Director | 1999-08-23 | 2000-10-27 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Id Medical Group Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2018-07-11 | Active |
| Dr Mahomed Hanif Allimahomed Sacoor | Individual | Shares 25–50% | 2016-06-30 | Ceased 2018-07-11 |
| Mr Michael Sacoor | Individual | Shares 25–50% | 2016-06-30 | Ceased 2018-07-11 |
Filing timeline
Last 20 of 142 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-02 | AA01 | accounts | Change account reference date company current shortened | |
| 2025-09-03 | AA | accounts | Accounts with accounts type full | |
| 2025-08-06 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-07-08 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2025-05-16 | TM01 | officers | Termination director company with name termination date | |
| 2024-11-05 | AA | accounts | Accounts with accounts type full | |
| 2024-08-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-03-19 | AA | accounts | Accounts with accounts type full | |
| 2024-01-15 | AP01 | officers | Appoint person director company with name date | |
| 2024-01-15 | AP01 | officers | Appoint person director company with name date | |
| 2024-01-15 | AP01 | officers | Appoint person director company with name date | |
| 2024-01-15 | TM01 | officers | Termination director company with name termination date | |
| 2024-01-15 | TM01 | officers | Termination director company with name termination date | |
| 2024-01-15 | TM01 | officers | Termination director company with name termination date | |
| 2024-01-15 | TM01 | officers | Termination director company with name termination date | |
| 2024-01-15 | TM01 | officers | Termination director company with name termination date | |
| 2024-01-15 | TM02 | officers | Termination secretary company with name termination date | |
| 2023-08-15 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-08-08 | TM01 | officers | Termination director company with name termination date | |
| 2023-04-12 | AP03 | officers | Appoint person secretary company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2024 → FY2025 · period ending 2025-03-31 vs 2024-03-31
-
Turnover
-26.4%
£227,422,268 £167,307,995
-
Cash
+35.6%
£451,802 £612,842
-
Net assets
+10.2%
£5,432,897 £5,985,998
-
Employees
-7.3%
245 227
-
Operating profit
-75.8%
£5,316,647 £1,285,084
-
Profit before tax
-83.9%
£4,309,454 £694,370
-
Wages
-13.5%
£13,600,875 £11,769,021
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers